| Product Code: ETC11489355 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Germany Cannabis Pharmaceuticals Market Overview |
3.1 Germany Country Macro Economic Indicators |
3.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, 2021 & 2031F |
3.3 Germany Cannabis Pharmaceuticals Market - Industry Life Cycle |
3.4 Germany Cannabis Pharmaceuticals Market - Porter's Five Forces |
3.5 Germany Cannabis Pharmaceuticals Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Germany Cannabis Pharmaceuticals Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Germany Cannabis Pharmaceuticals Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Germany Cannabis Pharmaceuticals Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.9 Germany Cannabis Pharmaceuticals Market Revenues & Volume Share, By Benefit, 2021 & 2031F |
4 Germany Cannabis Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing acceptance of medical cannabis in Germany |
4.2.2 Growing awareness about the therapeutic benefits of cannabis pharmaceuticals |
4.2.3 Favorable regulatory environment supporting the use of cannabis for medicinal purposes |
4.3 Market Restraints |
4.3.1 Stringent regulations and licensing requirements for cannabis pharmaceuticals |
4.3.2 Limited availability of medical professionals trained in prescribing cannabis-based treatments |
4.3.3 Challenges in insurance coverage for cannabis pharmaceuticals |
5 Germany Cannabis Pharmaceuticals Market Trends |
6 Germany Cannabis Pharmaceuticals Market, By Types |
6.1 Germany Cannabis Pharmaceuticals Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.4 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Oils, 2021 - 2031F |
6.1.5 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Topicals, 2021 - 2031F |
6.2 Germany Cannabis Pharmaceuticals Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Pain Management, 2021 - 2031F |
6.2.3 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Anxiety Relief, 2021 - 2031F |
6.2.4 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Skin Conditions, 2021 - 2031F |
6.3 Germany Cannabis Pharmaceuticals Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Patients, 2021 - 2031F |
6.3.3 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4 Germany Cannabis Pharmaceuticals Market, By Source |
6.4.1 Overview and Analysis |
6.4.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Cannabis-Based, 2021 - 2031F |
6.4.3 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Hemp-Based, 2021 - 2031F |
6.4.4 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Plant-Based, 2021 - 2031F |
6.5 Germany Cannabis Pharmaceuticals Market, By Benefit |
6.5.1 Overview and Analysis |
6.5.2 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Non-Psychoactive, 2021 - 2031F |
6.5.3 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Natural, 2021 - 2031F |
6.5.4 Germany Cannabis Pharmaceuticals Market Revenues & Volume, By Anti-Inflammatory, 2021 - 2031F |
7 Germany Cannabis Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Germany Cannabis Pharmaceuticals Market Export to Major Countries |
7.2 Germany Cannabis Pharmaceuticals Market Imports from Major Countries |
8 Germany Cannabis Pharmaceuticals Market Key Performance Indicators |
8.1 Number of new medical cannabis prescriptions issued by healthcare providers |
8.2 Research and development investments in cannabis pharmaceuticals by pharmaceutical companies |
8.3 Patient satisfaction and reported health improvements with cannabis-based treatments |
8.4 Number of clinical trials and studies conducted on cannabis pharmaceuticals |
8.5 Adoption rates of cannabis pharmaceuticals among different patient demographics |
9 Germany Cannabis Pharmaceuticals Market - Opportunity Assessment |
9.1 Germany Cannabis Pharmaceuticals Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Germany Cannabis Pharmaceuticals Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Germany Cannabis Pharmaceuticals Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Germany Cannabis Pharmaceuticals Market Opportunity Assessment, By Source, 2021 & 2031F |
9.5 Germany Cannabis Pharmaceuticals Market Opportunity Assessment, By Benefit, 2021 & 2031F |
10 Germany Cannabis Pharmaceuticals Market - Competitive Landscape |
10.1 Germany Cannabis Pharmaceuticals Market Revenue Share, By Companies, 2024 |
10.2 Germany Cannabis Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here